Vyndaqel savings card: as little as $0 a month with commercial insurance

How to pay the least

Ask for the cash price

Vyndaqel

We didn’t find one.

Ask your pharmacy for Vyndaqel’s cash price, and one or two other pharmacies too.
Vyndaqel’s savings card works only with insurance from a job or one you bought.

Compare every option

Brand nameVyndaqel

Authorized generictafamidis meglumine

Regular generictafamidis meglumine

What you’d pay

Cash priceAsk the pharmacy

Not soldThere isn’t one

Not soldNone found

Same as Vyndaqel?

The original

–

Brand nameThe maker’s card

VYNDAMAX/VYNDAQEL Co-Pay Savings Program (VyndaLink / VynAssist)

Savings card from Pfizer

No insuranceNeeds insuranceNo cash price listed.

Insurance · as little as $0 a month

The card takes up to $10,000–$60,000 a year off your co-pay.

Print the card from myvynassist.com

Or call 1-888-863-1177. See the offer on myvynassist.com

In the maker’s words

“If you are an eligible, commercially insured patient, you may pay as little as $0 per month for VYNDAMAX.”

From the maker’s offer on myvynassist.com, checked November 2, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

Maker’s card or discount card?

A discount card like GoodRx lowers the pharmacy’s cash price, but for a brand-name drug that price often stays high. Compare it with the maker’s card above. You can usually use one or the other on a fill, not both.

Authorized genericNot sold

There isn’t one. An authorized generic is Vyndaqel itself, from the same company, sold without the brand name, and usually for less. For now Vyndaqel is the only choice; its maker’s savings card can lower what you pay.

See the brand name →

Regular genericNot sold

We didn’t find one. Generics usually come once the brand’s patents and exclusivity end. Until then, the maker’s savings card is the way to pay less.

See the brand name →

What it’s used for

Heart muscle disease from transthyretin amyloidosis (ATTR-CM)

What the FDA label says

VYNDAQEL and VYNDAMAX are transthyretin stabilizers indicated for the treatment of the cardiomyopathy of wild-type or hereditary transthyretin-mediated amyloidosis in adults to reduce cardiovascular mortality and cardiovascular-related hospitalization.

Source: the FDA label for Vyndaqel (Pfizer Laboratories Div Pfizer Inc), May 12, 2026. Full label on DailyMed

Good to know

“Commercial insurance” means a plan from a job, from the marketplace, or one you buy yourself. A retiree plan that’s part of Medicare counts as Medicare. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.
Most cards need a sign-up on the maker’s site, and many work only if your plan covers the drug. Then give the card’s details to your pharmacy.
Don’t stop or change a medicine without talking to your pharmacist or prescriber.

Prices checked November 2, 2026. Prices change: confirm with the pharmacy before you fill. drugalt.com/drug/vyndaqel/